SUDEEPPHRM

- Mr. Sendhil Pani ceased to be Senior Management Personnel (Managing Director of Sudeep Pharma USA Inc.) w.e.f. October 2, 2026. - Cessation is due to the completion of contractual arrangements.

- Trading window for dealing in securities will be closed for Designated Persons from October 1, 2026. - Closure will remain until 48 hours after declaration of un-audited financial results for Q2/H1 ending September 30, 2026. - Board meeting date will be communicated in due course.

- Concall Schedule - Concall Date: 28th September 2026 - Concall Time: 10:00 am onwards - Organised by: Nuvama Emerging India CEO Forum 2026

- Sudeep Pharma Limited announced the cancellation of the Analyst / Investor Plant Visit. - The visit was scheduled for 23rd and 24th September 2026. - The cancellation is due to "some exigencies."

- Plant Visit Schedule for Analyst / Institutional Investor meetings - Date: 23rd & 24th September 2026 - Time: 11:00 am onwards - Place: Gujarat - Discussions will be based on publicly available information.